Skip to main content

Advertisement

Table 2 Impact of clinicopathological parameters on OS in DLBCL

From: Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma

  Total (n = 71) Number of events P value
Sex    0.219
 Men
 Women
38
33
16
10
Extranodal involvement    0.068
 Yes
 No
53
18
23
3
Stage    0.520
 I–II
 III–IV
18
53
8
18
Elevated LDHb    0.210
 Yes
 No
51
17
16
8
B symptomsb    0.149
 Yes
 No
20
49
10
15
IPI scoreb    0.431
 0–2
 3–5
26
42
8
16
Performance scorea    0.114
 0–2
 3–4
62
9
21
5
Responseb    0.061
 CR
 PD/PR
51
10
14
5
Age at diagnosis    0.059
 <60 years
 ≥60 years
30
41
7
19
Rituximabb    0.782
 Yes
 No
59
11
21
4
  1. LDH lactate dehydrogenase, IPI international prognostic index, CR complete response, PD progressive disease, PR partial response
  2. aEastern Cooperative Oncology Group
  3. bData was not available for all patients